CatalystWireBeta

Directorate Change

In brief · summary, not quotable

Non-executive director Carolina Margozzini resigned from the Board with immediate effect.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SRB notes

Serabi Gold plc (“Serabi” or the “Company”) (AIM: SRB, TSX: SBI, OTCQX : SRBIF), announces that on 21 April 2025, Carolina Margozzini, non-executive director and representative director of Fratelli Investments Limited, resigned from the Board of Serabi with immediate effect.

The Board of Directors expresses its gratitude to Ms. Margozzini for her significant contributions during her time with the Company.

Michael Hodgson, CEO of Serabi, commented:

“We thank Carolina for her service and insights to Serabi and we wish her continued success in all future endeavours.”

Assay results reported within this release include those provided by the Company's own on-site laboratory facilities at Palito and have not yet been independently verified. Serabi closely monitors the performance of its own facility against results from independent laboratory analysis for quality control purpose. As a matter of normal practice, the Company sends duplicate samples derived from a variety of the Company's activities to accredited laboratory facilities for independent verification. Since mid-2019, over 10,000 exploration drill core samples have been assayed at both the Palito laboratory and certified external laboratory, in most cases the ALS laboratory in Belo Horizonte, Brazil. When comparing significant assays with grades exceeding 1 g/t gold, comparison between Palito versus external results record an average over-estimation by the Palito laboratory of 6.7% over this period. Based on the results of this work, the Company's management are satisfied that the Company's own facility shows sufficiently good correlation with independent laboratory facilities for exploration drill samples. The Company would expect that in the preparation of any future independent Reserve/Resource statement undertaken in compliance with a recognized standard, the independent authors of such a statement would not use Palito assay results without sufficient duplicates from an appropriately certificated laboratory.

Notice

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note